A double-blind, placebo-controlled, crossover study to evaluate the effects of tiotropium bromide on gas exchange in subjects with COPD during exercise.
Phase of Trial: Phase IV
Latest Information Update: 27 Oct 2009
At a glance
- Drugs Tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacodynamics
- 27 Oct 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 20 Oct 2009 Actual end date (Apr 2009) added as reported by ClinicalTrials.gov.
- 28 Jul 2009 Planned end date added to 1 Mar 2009 as reported by ClinicalTrials.gov.